Cite
HARVARD Citation
Bhardwaj, R. et al. (2022). P‐Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects. Clinical pharmacology in drug development. 11 (7), pp. 889-897. [Online].